Showing results (1-10 of 143) with videos related to
Sort By:
Pageof 15
Journal of Cardiovascular Pharmacology|June 21, 2006
A European's perspective of COX-2 drug safetyThomas M MacDonaldBasic & Clinical Pharmacology & Toxicology|April 14, 2006
Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?Thomas M MacDonald, Li WeiExpert Opinion on Pharmacotherapy|February 28, 2002
Gastrointestinal side effects of NSAIDs - pharmacoeconomic implicationsChristopher L Sheen, Thomas M MacDonaldCurrent Hypertension Reports|March 17, 2007
Mineralocorticoid receptor antagonistsHari Krishnan Parthasarathy, Thomas M MacDonaldExpert Opinion on Pharmacotherapy|January 12, 2010
Treatment of osteoarthritis in hypertensive patientsIsla S Mackenzie, Thomas M MacDonaldBritish Journal of Clinical Pharmacology|February 19, 2008
Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United KingdomThomas M MacDonald, Steven V MorantCardiovascular Research|February 27, 2004
Review of aldosterone- and angiotensin II-induced target organ damage and preventionAllan D Struthers, Thomas M MacDonaldPharmacoepidemiology and Drug Safety|May 25, 2007
Channelling of SSRIs and SNRIs use in the Tayside population, ScotlandLi Wei, Ruoling Chen, Thomas M MacDonaldBritish Journal of Clinical Pharmacology|May 22, 2008
Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcomeLi Wei, Tom Fahey, Thomas M MacDonaldEuropean Journal of Clinical Pharmacology|June 27, 2012
Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritisIsla S Mackenzie, Li Wei, Thomas M MacdonaldPageof 15